Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling.

Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling.
复制标题

DOI:
10.1016/j.cmet.2012.03.008
复制
发表时间:
2012-04-04
期刊:
影响因子:
29
通讯作者:
Puigserver P
Puigserver P
中科院分区:
生物学1区
文献类型:
--
作者:
Blättler SM;Cunningham JT;Verdeguer F;Chim H;Haas W;Liu H;Romanino K;Rüegg MA;Gygi SP;Shi Y;Puigserver P

文献摘要

参考文献

被引文献

相似文献

雷帕霉素及其衍生物是用于组织移植和癌症治疗的mTOR抑制剂。接受这些抑制剂治疗的患者中有一定比例会出现糖尿病样症状,但其分子机制尚不清楚。我们在这里表明,长期雷帕霉素治疗小鼠导致胰岛素抵抗,抑制胰岛素/IGF信号传导和该途径中相关的基因,如IGFs,IRS 1/2和AKT。重要的是,骨骼肌特异性YY 1基因敲除小鼠受到保护,免受雷帕霉素诱导的糖尿病样症状。这种保护作用是由胰岛素/IGF信号的过度激活引起的,与野生型小鼠相比,这种级联反应中的基因增加,不受雷帕霉素抑制。从机制上讲,雷帕霉素诱导YY 1去磷酸化和招募胰岛素/IGF基因的启动子,这促进了与polycomb蛋白-2辅阻遏物的相互作用。这与H3 K27三甲基化相关,导致基因表达和胰岛素信号转导减少。这些结果对雷帕霉素在人类疾病和生物学过程中的作用有影响,例如长寿。
Rapamycin and derivatives are mTOR inhibitors used in tissue transplantation and cancer therapy. A percentage of patients treated with these inhibitors develop diabetic-like symptoms but the molecular mechanisms are unknown. We show here that chronic rapamycin treatment in mice leads to insulin resistance with suppression of insulin/IGF signaling and genes associated within this pathway, such as IGFs, IRS1/2 and AKTs. Importantly, skeletal muscle-specific YY1 knockout mice were protected from rapamycin-induced diabetic-like symptoms. This protection was caused by hyperactivation of insulin/IGF signaling with increases in genes in this cascade that, in contrast to wild-type mice, were not suppressed by rapamycin. Mechanistically, rapamycin induced YY1 dephosphorylation and recruitment to promoters of insulin/IGF genes, which promoted interaction with the polycomb protein-2 corepressor. This was associated with H3K27 tri-methylation leading to decreases in gene expression and insulin signaling. These results have implications for rapamycin action in human diseases and biological processes, such as longevity.
DOI: 10.2337/db09-1324
发表时间: 2010-06
期刊: Diabetes
影响因子: 7.7
作者:
Houde VP;Brûlé S;Festuccia WT;Blanchard PG;Bellmann K;Deshaies Y;Marette A
通讯作者: Marette A
DOI: 10.1038/nature06322
发表时间: 2007-11-29
期刊: NATURE
影响因子: 64.8
作者:
Cunningham, John T.;Rodgers, Joseph T.;Puigserver, Pere
通讯作者: Puigserver, Pere
DOI: 10.1016/j.cmet.2009.11.010
发表时间: 2010-01
期刊: Cell metabolism
影响因子: 29
作者:
Bjedov I;Toivonen JM;Kerr F;Slack C;Jacobson J;Foley A;Partridge L
通讯作者: Partridge L
DOI: 10.1038/nm0410-400
发表时间: 2010-04
期刊: Nature medicine
影响因子: 82.9
作者:
Erion DM;Shulman GI
通讯作者: Shulman GI
DOI: 10.1016/j.molcel.2010.06.022
发表时间: 2010-07-30
期刊: Molecular cell
影响因子: 16
作者:
Düvel K;Yecies JL;Menon S;Raman P;Lipovsky AI;Souza AL;Triantafellow E;Ma Q;Gorski R;Cleaver S;Vander Heiden MG;MacKeigan JP;Finan PM;Clish CB;Murphy LO;Manning BD
通讯作者: Manning BD